Serum melatonin is an alternative index of Parkinson's disease severity

Ling Lin,Yuequn Du,Sutao Yuan,Jie Shen,Xiang Lin,Zhihong Zheng
DOI: https://doi.org/10.1016/j.brainres.2013.12.021
IF: 3.61
2014-02-01
Brain Research
Abstract:The protective potential of melatonin (MLT) in Parkinson's disease (PD) is the subject of considerable controversy. The purpose of the present study was to investigate serum MLT levels in unilateral 6-hydroxydopamine (6-OHDA) lesion rats and patients with PD. Blood samples were collected from rats at 10:00 am and from patients with PD and healthy subjects between 8:00 and 10:00 am. Serum MLT levels were measured using the enzyme-linked immunosorbent assay. Our results revealed that the morning serum MLT levels either in 6-OHDA-induced hemi-parkinsonian rats or patients with PD were significantly higher than that of control group. Our results also demonstrate that serum MLT levels are correlated with severity of PD according to H & Y scale.
neurosciences
What problem does this paper attempt to address?